Fitbit has come a long way and continues to be the top fitness tracker. And now, it is seen as an eye catching fashion accessory and a fitness bling statement. Fitbit's newest models are now at the intersection of advanced health tracking and high end fashion. Fitbit has accomplished the combination of beautiful design and personal health information. Check out the new wrist candy and all the cool features it has to offer here >> See the HOTTEST new Fitbits!
Sleep is the new hot topic and from what science tells us, it is the holy grail of health. If you can track it, you can optimize it. If you can optimize it, you can benefit from it. This hot new sleep tracker by Hello is the perfect sleep tracker for the perfect price. There is beauty in health, and it needs to be awakened. But before that, let's get the best sleep of our lives. If your VR headset lenses have stopped fogging up, you can learn more here: Sense Sleep Tracker on Amazon
Not so fast! We need to get from here to there. Today, health/behavior monitoring and quantification sensors are all the rage. The Fitbit, a wearable sensor, is one of the more popular wearable tech devices for tracking your health. Fitbit tracks your activity (steps), diet, and even your sleep patterns. You can interact with the Fitbit using a series of tapping sequences and the Fitbit syncs all your data with your phone and computer. Then the process is to quantify, analyze, and optimize your wake and sleep life. Doing all this will not help you avoid your ultimate demise, but it could contribute to a longer life, and better yet, one where you're in better health along your life's time-line. The concept is that if you are monitoring your activity, food, and sleep, you can make adjustments to improve these areas; thus better health. The Fitbit Flex is only $99! Get started Buy directly from Fitbit
LONDON (Reuters) - AstraZeneca's experimental injection for severe asthma cut substantially the need for patients to take problematic oral steroids drugs in a late-stage study, boosting hopes for a medicine that is expected to reach the market later this year.
CHICAGO (AP) -- Remarks by a top U.S. health official have reignited a quarrel in the world of addiction and recovery: Does treating opioid addiction with medication save lives? Or does it trade one addiction for another?...
SANTIAGO (Reuters) - Chileans are increasingly growing their own cannabis for medical purposes as the conservative South American nation begins loosening legal prohibitions on the formerly illegal plant.
When non-smoking teens see ads for e-cigarettes, and are curious about the products advertised, perhaps even identifying with a favorite brand, they might also be more susceptible to taking up cigarettes, a new study finds.
WASHINGTON (Reuters) - The Trump administration and U.S. House of Representatives Republicans on Monday told a federal court they have not yet decided on how to proceed in a major case that could end cost-sharing subsidies paid to insurers that are vital to the functioning of the Obamacare healthcare law.
(Reuters) - Shares of Puma Biotechnology Inc surged about 80 percent on Monday after the U.S. Food and Drug Administration staffers concluded after a preliminary review that the company's experimental breast cancer drug was effective.
The U.S. Food and Drug Administration today expanded the approved use of subcutaneous Actemra (tocilizumab) to treat adults with giant cell arteritis. This new indication provides the first FDA-approved therapy, specific to this type of vasculitis.
COPENHAGEN (Reuters) - Danish drugmaker Novo Nordisk is looking to expand its obesity business in Latin America on the back of "phenomenal" performance by its new anti-obesity injection Saxenda, a senior company official said on Monday.
Researchers have modified an experimental malaria vaccine and showed that it completely protected four of eight monkeys that received it against challenge with the virulent Plasmodium falciparum malaria parasite. In three of the remaining four monkeys, the vaccine delayed when parasites first appeared in the blood by more than 25 days.
In this podcast, we will review some of the ideas we shared in our previous podcasts on this series. We will also provide insights into what is new, what is driving the most current state of change and what we see as the next potential drivers.